Trials / Completed
CompletedNCT05274321
Efficacy of the Nanodropper Device on Pupillary Dilation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- University of California, San Francisco · Academic / Other
- Sex
- All
- Age
- 2 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
Prescription eye drop bottles elute drops that exceed the capacity of the human eye by five times. This study describes performing in clinic dilation using a novel solution for combating medical waste with Nanodropper, an eye drop bottle adapter that creates smaller eye drops.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Nanodropper | Device used for administering eye drops |
| DEVICE | Standard Eye Dropper | Standard Eye Dropper used for administering eye drops |
Timeline
- Start date
- 2021-07-29
- Primary completion
- 2021-11-19
- Completion
- 2021-11-19
- First posted
- 2022-03-10
- Last updated
- 2023-09-25
- Results posted
- 2023-09-25
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05274321. Inclusion in this directory is not an endorsement.